LEO Pharma
Manufacturing · 11-50 Employees
View Company Info for Free
Overview
Website
www.adbry.comRevenue
<$5 MillionIndustry
ZI Rank: 1
Signal Type
Jan
Feb
Mar
Apr
May
Jun
ZI Rank
1
1
1
1
1
1
About LEO Pharma
LEO Pharma Inc. offers Adbry® (tralokinumab-ldrm), an injectable prescription treatment designed for adults with uncontrolled, moderate-to-severe eczema (atopic dermatitis). The company provides resources and support programs for patients and caregivers, including the Adbry Advocate Program, aimed at helping users manage their conditions. Adbry® can be administered with or without topical corticosteroids and is intended for individuals who have not found relief from traditional topical therapies. The focus of LEO Pharma Inc. is on improving the quality of life for patients suffering from eczema.Explore more
Popular SearchesLEO Pharma IncAdbrySIC Code 28,283NAICS Code 32,325Show more
Sell smarter with deeper company insights.
ZoomInfo gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Is LEO Pharma your ideal customer? 
Let us give you the heads up on whether it's a good time to reach out
Product Launch: Get notified when LEO Pharma launches new products
Website visits: Recent activity has been detected on your website
Check if LEO Pharma has recently received funding, and reach out quickly before it becomes old news!
Earning: See what the market has to say on LEO Pharma recently announced quarterly report
Congratulate Masked Content for being promoted to Masked Content at LEO Pharma
LEO Pharma, which may be a good buyer, showed buying intent in Masked Content Topic
Funding: Get notified immidiatlly once LEO Pharma has new funding data
Competitive Alert! Recent activity has been detected by your competitor Masked Content
Click to see if LEO Pharma had a recent Job posting/layoffs
Check out if LEO Pharma is spiking on competitors!
Recommended Actions
Reach out to Masked Content who joined LEO Pharma as Masked Content
Find 3 more new buyers
Compare Similar Companies to LEO Pharma
Compare insights from companies similar to LEO Pharma, focusing on performance, financial data, growth rates, and unique benchmarks to identify key industry trends and opportunities.
Revenue
Number of Employees
Type
Funding
Founded In
LEO Pharma
<$5M
11-50
Private
-
-
N/A
Company Profile Activity
Activity Insights
LEO Pharma is experiencing very low activity levels compared to other companies in the Manufacturing sector.
What does this means?
LEO Pharma is drawing exceptional interest within the Manufacturing industry, suggesting notable developments or strong market momentum, learn more about LEO Pharma.
LEO Pharma Tech Stack
A closer look at the technologies used by LEO Pharma
See more technologies
Top Manufacturing Companies
Top companies in Canada by revenue
Top companies in Australia by revenue
Top companies in New Zealand by revenue
Frequently Asked Questions Regarding LEO Pharma
Sign Up For FreeTo access detailed company insights
LEO Pharma Inc. offers Adbry® (tralokinumab-ldrm), an injectable prescription treatment designed for adults with uncontrolled, moderate-to-severe eczema (atopic dermatitis). The company provides resources and support programs for patients and caregivers, including the Adbry Advocate Program, aimed at helping users manage their conditions. Adbry® ca... Read More
